|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Cost of revenue, excluding depreciation and amortization | |||||
| Research and development, net | |||||
| Clinical operations, net | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment of goodwill | |||||
| Depreciation and amortization | |||||
| Total costs and operating expenses | |||||
| Income (loss) from operations | |||||
| Financial income, net | |||||
| Income (loss) before income taxes | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Comprehensive loss | |||||
| Basic | |||||
| Diluted | |||||
Loading...